Media.Player

Regulation of the vaginal microbiome reduces rate of HIV infection

总结

This technology is a combination of vaccines, probiotics, and antibiotics that regulate the vaginal microbiome to reduce the infection rate of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs).

技术优势

Cost-effective prevention of HIV infectionAlso reduces risk of infection with other STIs

技术应用

Preventative vaccine to reduce HIV infection risk Antibiotics for prevention of HIV and STIsVaginal probiotics to maintain a healthy bacterial microbiome

详细技术说明

None

*Abstract

None

*Inquiry

Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu

*IR

CU17009

*Principal Investigation

*Publications

Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS. “Genital inflammation and the risk of HIV acquisition in women.” Clin Infect Dis. 2015 Jul 15;61(2):260-9.Tech Ventures Reference:IR CU17009Licensing Contact: Ron Katz

国家/地区

美国